• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Glycosylation Characterization of an Influenza H5N7 Hemagglutinin Series with Engineered Glycosylation Patterns: Implications for Structure-Function R

tetano

Editor, Senior Moderator
J Proteome Res. 2016 Dec 5. doi: 10.1021/acs.jproteome.6b00175. [Epub ahead of print]
[h=1]Glycosylation Characterization of an Influenza H5N7 Hemagglutinin Series with Engineered Glycosylation Patterns: Implications for Structure-Function Relationships.[/h] Parsons LM[SUP]1[/SUP], An Y[SUP]1[/SUP], de Vries RP[SUP]2[/SUP], de Haan CA[SUP]3[/SUP], Cipollo JF[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The glycosylation patterns of four recombinant H5 hemagglutinins (HAs) derived from A/Mallard/Denmark/64650/03 (H5N7) have been characterized. The proteins were expressed in (i) HEK293T cells to produce complex glycoforms, (ii) HEK293T cells treated with Vibrio cholera neuraminidase to provide asialo-complex glycoforms, (iii) HEK293S GnTI(-) cells with predominantly the canonical Man[SUB]5[/SUB]GlcNAc[SUB]2[/SUB] glycoform, and (iv) Drosophila S2 insect cells producing primarily paucimannose glycoforms. Previously, these HAs were used to investigate the effect of different glycosylation states on the immune responses in chicken and mouse systems. Evidence was found that high-mannose glycans diminished antibody response via DC-SIGN interactions. We performed two semiquantitative analyses including MALDI-TOF MS permethylation analysis of released glycans and LC-MS[SUP]E[/SUP] analysis of glycosylation site microheterogeneity. Glycosylation site occupancy was also determined by LC-MS[SUP]E[/SUP]. Our major findings include (1) decreasing complexity of glycosylation from the stem to the globular head, (2) absence of glycosylation at N[SUP]10[/SUP] and N[SUP]193[/SUP], (3) complex glycans at N[SUP]165[/SUP] in HEK293T cell HA but high mannose glycans at this site in HEK293S and S2 cells, and (4) differences between the three-dimensional structures of H3 and H5 HAs that may explain glycan type preferences at selected sites. Biological implications of the findings are discussed.


[h=4]KEYWORDS:[/h] GLYMPS; HEK293; S2; flu; glycosylation; hemagglutinin; influenza; mass spectrometry

PMID: 28060516 DOI: 10.1021/acs.jproteome.6b00175
[PubMed - as supplied by publisher]
 
Back
Top Bottom